BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26261495)

  • 1. Alternative splicing of NUMB, APP and VEGFA as the features of pancreatic ductal carcinoma.
    Zheng KL; He TL; Ji WP; Jiang H; Shen Y; Li G; Zhu SB; Tong BL; Zhang YJ
    Int J Clin Exp Pathol; 2015; 8(6):6181-91. PubMed ID: 26261495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative splicing of VEGFA, APP and NUMB genes in colorectal cancer.
    Zhao YJ; Han HZ; Liang Y; Shi CZ; Zhu QC; Yang J
    World J Gastroenterol; 2015 Jun; 21(21):6550-60. PubMed ID: 26074693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survival.
    Ye HL; Li DD; Lin Q; Zhou Y; Zhou QB; Zeng B; Fu ZQ; Gao WC; Liu YM; Chen RW; Li ZH; Chen RF
    World J Gastroenterol; 2015 Jun; 21(21):6621-30. PubMed ID: 26074700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The relationship and clinicopathological significance of Numb,MDM2 and p53 expression in human pancreatic cancer].
    Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F
    Zhonghua Wai Ke Za Zhi; 2014 Sep; 52(9):675-81. PubMed ID: 25410780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Numb/Notch signaling pathway modulation enhances human pancreatic cancer cell radiosensitivity.
    Bi YL; Min M; Shen W; Liu Y
    Tumour Biol; 2016 Nov; 37(11):15145-15155. PubMed ID: 27677287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global profiling and molecular characterization of alternative splicing events misregulated in lung cancer.
    Misquitta-Ali CM; Cheng E; O'Hanlon D; Liu N; McGlade CJ; Tsao MS; Blencowe BJ
    Mol Cell Biol; 2011 Jan; 31(1):138-50. PubMed ID: 21041478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NOTCH1, NOTCH3, NOTCH4, and JAG2 protein levels in human endometrial cancer.
    Sasnauskienė A; Jonušienė V; Krikštaponienė A; Butkytė S; Dabkevičienė D; Kanopienė D; Kazbarienė B; Didžiapetrienė J
    Medicina (Kaunas); 2014; 50(1):14-8. PubMed ID: 25060200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of transcriptome data identifies a novel 5-gene pancreatic adenocarcinoma classifier.
    Bhasin MK; Ndebele K; Bucur O; Yee EU; Otu HH; Plati J; Bullock A; Gu X; Castan E; Zhang P; Najarian R; Muraru MS; Miksad R; Khosravi-Far R; Libermann TA
    Oncotarget; 2016 Apr; 7(17):23263-81. PubMed ID: 26993610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delta-like 4/Notch pathway is differentially regulated in benign and malignant thyroid tissues.
    Geers C; Colin IM; Gérard AC
    Thyroid; 2011 Dec; 21(12):1323-30. PubMed ID: 22066479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition on Numb/Notch signal pathway enhances radiosensitivity of lung cancer cell line H358.
    Song SG; Yu HY; Ma YW; Zhang F; Xu XY
    Tumour Biol; 2016 Oct; 37(10):13705-13719. PubMed ID: 27476167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression.
    Wang WY; Hsu CC; Wang TY; Li CR; Hou YC; Chu JM; Lee CT; Liu MS; Su JJ; Jian KY; Huang SS; Jiang SS; Shan YS; Lin PW; Shen YY; Lee MT; Chan TS; Chang CC; Chen CH; Chang IS; Lee YL; Chen LT; Tsai KK
    Gastroenterology; 2013 Nov; 145(5):1110-20. PubMed ID: 23896173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma.
    Nagao Y; Hisaoka M; Matsuyama A; Kanemitsu S; Hamada T; Fukuyama T; Nakano R; Uchiyama A; Kawamoto M; Yamaguchi K; Hashimoto H
    Mod Pathol; 2012 Jan; 25(1):112-21. PubMed ID: 21983937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel alternative splicing transcript variant of the suppressor of fused: Relationship with lymph node metastasis in pancreatic ductal adenocarcinoma.
    Xu Q; Gao J; Li Z
    Int J Oncol; 2016 Dec; 49(6):2611-2619. PubMed ID: 27840902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and clinical significance of Tspan 1 and Integrin α6 in human pancreatic ductal adenocarcinoma].
    Shi G; Dong M; Sheng W; Zhou J; Yu D; Sun W
    Zhonghua Wai Ke Za Zhi; 2014 Oct; 52(10):781-6. PubMed ID: 25573220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATP11A promotes EMT by regulating Numb PRR
    Chen L; Tang J; Sheng W; Sun J; Ma Y; Dong M
    PeerJ; 2022; 10():e13172. PubMed ID: 35345586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The microRNA-218 and ROBO-1 signaling axis correlates with the lymphatic metastasis of pancreatic cancer.
    He H; Di Y; Liang M; Yang F; Yao L; Hao S; Li J; Jiang Y; Jin C; Fu D
    Oncol Rep; 2013 Aug; 30(2):651-8. PubMed ID: 23733161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative splicing of the cell fate determinant Numb in hepatocellular carcinoma.
    Lu Y; Xu W; Ji J; Feng D; Sourbier C; Yang Y; Qu J; Zeng Z; Wang C; Chang X; Chen Y; Mishra A; Xu M; Lee MJ; Lee S; Trepel J; Linehan WM; Wang X; Yang Y; Neckers L
    Hepatology; 2015 Oct; 62(4):1122-31. PubMed ID: 26058814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SERP1 is a novel marker of poor prognosis in pancreatic ductal adenocarcinoma patients via anti-apoptosis and regulating SRPRB/NF-κB axis.
    Ma Q; Wu X; Wu J; Liang Z; Liu T
    Int J Oncol; 2017 Oct; 51(4):1104-1114. PubMed ID: 28902358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between ECT2 gene expression and methylation change of ECT2 promoter region in pancreatic cancer.
    Zhang ML; Lu S; Zhou L; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):533-8. PubMed ID: 18842503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Confirmation of DNA microarray-derived differentially expressed genes in pancreatic cancer using quantitative RT-PCR.
    Streit S; Michalski CW; Erkan M; Friess H; Kleeff J
    Pancreatology; 2009; 9(5):577-82. PubMed ID: 19657213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.